Decheng Capital Management III (Cayman)’s Whitehawk Therapeutics WHWK Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.55M	Hold	526,329	–	–	0.85%	20
2023 Q2	$3.6M	Hold	526,329	–	–	1.13%	16
2023 Q1	$3.81M	Hold	526,329	–	–	1.54%	14
2022 Q4	$6.75M	Hold	526,329	–	–	2.53%	13
2022 Q3	$7.44M	Hold	526,329	–	–	2.7%	12
2022 Q2	$6.48M	Hold	526,329	–	–	2.46%	12
2022 Q1	$8.93M	Buy	+526,329	New	+$10.1M	2.74%	13

Other funds holding WHWK

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Decheng Capital Management III (Cayman)'s WHWK Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) held its Whitehawk Therapeutics (WHWK) position steady in Q3 2023 at 526,329 shares worth $2.55M. The position accounts for 0.85% of the portfolio, ranked #20.

Decheng Capital Management III (Cayman) first reported a position in WHWK in Q1 2022 and has held it in 7 quarters since. The position peaked at $8.93M in Q1 2022. 73 funds tracked by Wall St. Rank hold WHWK as of Q3 2023.

Decheng Capital Management III (Cayman) held 526,329 shares of Whitehawk Therapeutics worth $2.55M as of Q3 2023.
Decheng Capital Management III (Cayman) left its Whitehawk Therapeutics share count unchanged in Q3 2023.
Whitehawk Therapeutics made up 0.85% of Decheng Capital Management III (Cayman)'s portfolio in Q3 2023, its #20 holding.
Decheng Capital Management III (Cayman) first reported a position in Whitehawk Therapeutics in Q1 2022 and has held it in 7 quarters since.
Decheng Capital Management III (Cayman)'s Whitehawk Therapeutics position peaked at $8.93M in Q1 2022.
73 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.